Abbott, Biocompatibles To Initiate Drug-Coated Stent Trial By Year-End
This article was originally published in The Gray Sheet
Executive Summary
Abbott Laboratories expects to begin human clinical trials of a drug-coated stent for in-stent restenosis with partner Biocompatibles by the end of 2001.